SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-119227
Filing Date
2023-11-17
Accepted
2023-11-17 06:00:34
Documents
1
Group Members
AH BIO FUND III, L.P.AH EQUITY PARTNERS BIO II, L.L.C.AH EQUITY PARTNERS BIO III, L.L.C.AH EQUITY PARTNERS LSV I, L.L.C.AH EQUITY PARTNERS LSV II, L.L.C.ANDREESSEN HOROWITZ LSV FUND I, L.P.ANDREESSEN HOROWITZ LSV FUND II, L.P.BENJAMIN HOROWITZMARC ANDREES

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2331002d1_sc13da.htm SC 13D/A 132566
  Complete submission text file 0001104659-23-119227.txt   134489
Mailing Address 2865 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025
Business Address 2865 SAND HILL ROAD, SUITE 101 MENLO PARK CA 94025 650-798-3900
AH Bio Fund II, L.P. (Filed by) CIK: 0001725721 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 (617) 315-2255
EQRx, Inc. (Subject) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93138 | Film No.: 231416333
SIC: 2834 Pharmaceutical Preparations